Argent BioPharma Limited
RGTLF
$0.0599
$0.011423.51%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -31.55% | -5.15% | 17.92% | 24.88% | 30.28% |
| Total Depreciation and Amortization | 63.59% | 23.76% | -17.20% | 49.98% | 399.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 952.42% | 115.50% | -41.05% | -67.00% | -86.29% |
| Change in Net Operating Assets | -165.27% | -165.27% | -165.27% | -83.29% | -0.89% |
| Cash from Operations | 16.40% | -1.34% | -19.18% | -4.56% | 7.43% |
| Capital Expenditure | -510.95% | -68.08% | 27.59% | 85.98% | 105.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -99.01% | -98.57% |
| Cash from Investing | -317.94% | -139.93% | -122.63% | -104.34% | -95.57% |
| Total Debt Issued | -- | -- | -- | -87.59% | -71.81% |
| Total Debt Repaid | -25.10% | -21.91% | -18.71% | 0.63% | 16.64% |
| Issuance of Common Stock | -68.32% | 2.77% | 416.44% | 998.35% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 96.62% | 62.02% | -37.32% | -307.99% | -7,028.13% |
| Cash from Financing | -70.60% | -27.22% | 52.36% | 116.75% | 236.68% |
| Foreign Exchange rate Adjustments | -95.35% | -91.30% | -300.00% | 66.67% | 68.84% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -209.23% | -248.07% | 124.64% | 162.26% | 170.17% |